Search

everythinglearnresearchcommunity

for

Search:↓

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Certain genetic variations in the RAB5B gene are linked to a higher risk of polycystic ovary syndrome in Chinese Han women.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Adult female acne is complex and requires a combination of treatments for effective management.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Ring Chromosome 11 may be linked to conditions like early puberty, excessive hair growth, hair loss, and type 2 diabetes.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Some women with PCOS have rare genetic variants linked to the condition.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.